
{!{wpv-post-title}!}
Our project addresses a problem in the Ontario Institute of Regenerative Medicine’s (OIRM’s) evaluation of Disease Team grant proposals. Applicants preparing for clinical trials were often unaware of their project’s place in the Disease Team funding spectrum. Further, reviewers found it challenging to convey their feedback in a succinct, tailored manner, given the wide variety of proposals they receive.
Students:

Dr. Vaishnavi Batmanabane
MD, MHSc

Ms. Meghan Lofft
BSc, MHSc
Capstone Supervisor:

Prof. Joseph Ferenbok
Capstone Advisory Committee:

Janet

Kelley

Elise

Sandra
{!{wpv-post-featured-image size=”et-pb-portfolio-image”}!}
{!{wpv-post-title}!}

Dr. Vaishnavi Batmanabane
MD, MHSc

Ms. Meghan Lofft
BSc, MHSc
Our project addresses a problem in the Ontario Institute of Regenerative Medicine’s (OIRM’s) evaluation of Disease Team grant proposals. Applicants preparing for clinical trials were often unaware of their project’s place in the Disease Team funding spectrum. Further, reviewers found it challenging to convey their feedback in a succinct, tailored manner, given the wide variety of proposals they receive.
Capstone Supervisor:

Prof. Joseph Ferenbok
Capstone Advisory Committee:

Janet

Kelley

Elise

Sandra